Glands and other organs for organo-therapeutic uses, dried, etc.: South Korea exports and imports
HS 3001 · 장기(臟器) 요법용 선(腺)과 그 밖의 기관(건조한 것으로 한정하며, 가루로 된 것인지에 상관없다), 선(腺)과 그 밖의 기관이나 이들의 분비물의 추출물로서 장기(臟器) 요법용의 것, 헤파린과 그 염, 치료용ㆍ예방용으로 조제한 그 밖의 인체물질이나 동물의 물질로서 따로 분류되지 않은 것 · latest month: October 2026
In October 2026, South Korea exported $4.6 million of glands and other organs for organo-therapeutic uses, dried, etc. (HS 3001), down 65.2% from September 2026 and up 0.1% from October 2025.
Over the 12 months to October 2026, exports of glands and other organs for organo-therapeutic uses, dried, etc. (HS 3001) totalled $64.6 million, up 2.1% from the 12 months before ($63.3 million).
The largest destination over the 12 months to October 2026 was Russia ($14.9 million, 23.1% of the total), followed by France and Egypt.
That was 0.6% of South Korea's exports under HS chapter 30 (pharmaceutical products) over the same 12 months.
Imports in October 2026 were $11.3 million (up 26.5% from October 2025), leaving a deficit of $6.7 million for the month.
Official description of HS 3001: Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included.
Last 24 months
Subheadings under HS 3001
| Code | Product | Exports, 12 months | Share | vs 12 months before | October 2026 |
|---|---|---|---|---|---|
| 3001.20 | Extracts of glands or other organs or of their secretions | $24K | 0.0% | -84.6% | $5,897 |
| 3001.20.2000 | Liver extracts | $167 | 0.7% | – | $0 |
| 3001.20.9000 | Other | $24K | 99.3% | -84.7% | $5,897 |
| 3001.90 | Other | $64.6M | 100.0% | +2.3% | $4.6M |
| 3001.90.1010 | Of human body | $24.0M | 37.2% | +30.8% | $2.0M |
| 3001.90.1090 | Other | $157K | 0.2% | -86.7% | $20K |
| 3001.90.2010 | Bear's gall | $25K | 0.0% | – | $0 |
| 3001.90.2090 | Other | $63K | 0.1% | -83.5% | $7,479 |
| 3001.90.9010 | Heparin and its salts | $445K | 0.7% | -77.4% | $0 |
| 3001.90.9020 | Of human body | $2.4M | 3.7% | +36.8% | $180K |
| 3001.90.9090 | Other | $37.5M | 58.0% | -5.1% | $2.5M |
Six-digit codes are international; the indented ten-digit codes are South Korea's own subdivision. These rows are world totals; "Share" is the share of the row above.
Top destinations
Export value over the 12 months to October 2026. 76 countries received this product from South Korea in the last 24 months; the table shows the largest 20.
| Rank | Country | Exports, 12 months | Share | vs 12 months before | Rank before | October 2026 |
|---|---|---|---|---|---|---|
| 1 | Russia | $14.9M | 23.1% | -5.8% | 1 | $1.9M |
| 2 | France | $9.2M | 14.2% | +10.9% | 3 | $0 |
| 3 | Egypt | $7.3M | 11.2% | -37.1% | 2 | $0 |
| 4 | Japan | $5.5M | 8.6% | -11.5% | 4 | $188K |
| 5 | United States | $5.1M | 7.8% | +109.9% | 7 | $352K |
| 6 | China | $4.8M | 7.4% | +50.3% | 6 | $332K |
| 7 | Taiwan | $3.3M | 5.0% | -2.1% | 5 | $356K |
| 8 | Canada | $2.9M | 4.5% | +42.2% | 8 | $114K |
| 9 | Malaysia | $2.0M | 3.2% | +109.0% | 11 | $363K |
| 10 | Singapore | $1.7M | 2.6% | +461.7% | 18 | $224K |
| 11 | Thailand | $1.0M | 1.6% | -50.6% | 9 | $97K |
| 12 | Belarus | $863K | 1.3% | -13.9% | 10 | $0 |
| 13 | Mexico | $759K | 1.2% | +234.1% | 22 | $22K |
| 14 | Vietnam | $560K | 0.9% | -25.6% | 12 | $22K |
| 15 | Mongolia | $412K | 0.6% | +116.5% | 23 | $45K |
| 16 | Saudi Arabia | $351K | 0.5% | +51.0% | 20 | $0 |
| 17 | Philippines | $351K | 0.5% | -31.8% | 15 | $24K |
| 18 | Türkiye | $347K | 0.5% | -43.9% | 13 | $14K |
| 19 | Colombia | $329K | 0.5% | -40.6% | 14 | $8,700 |
| 20 | Myanmar | $292K | 0.5% | – | 56 | $76K |
Countries are linked when exports of this product to them reached $5,000,000 over 24 months.
Monthly figures
| Month | Exports | vs year earlier | Export weight | Export $/kg | Imports | Import weight |
|---|---|---|---|---|---|---|
| October 2026 | $4.6M | +0.1% | 2.3 t | $2,034.84 | $11.3M | 13.9 t |
| September 2026 | $13.4M | +13.0% | 3.9 t | $3,385.08 | $7.2M | 12.6 t |
| August 2026 | $2.9M | +27.3% | 3.3 t | $872.15 | $7.5M | 13.3 t |
| July 2026 | $5.7M | +84.6% | 2.3 t | $2,498.62 | $10.9M | 16.2 t |
| June 2026 | $3.2M | +39.3% | 4.3 t | $742.17 | $10.1M | 17.8 t |
| May 2026 | $9.0M | -45.0% | 3.1 t | $2,910.43 | $8.8M | 14.1 t |
| April 2026 | $3.5M | +71.3% | 3.5 t | $989.17 | $8.9M | 14.4 t |
| March 2026 | $7.5M | +79.6% | 4.2 t | $1,808.07 | $9.3M | 17.5 t |
| February 2026 | $5.1M | +21.9% | 5.6 t | $907.57 | $8.1M | 12.8 t |
| January 2026 | $2.9M | +38.3% | 4.9 t | $587.29 | $10.0M | 10.1 t |
| December 2025 | $5.1M | -13.9% | 3.4 t | $1,498.17 | $9.6M | 14.2 t |
| November 2025 | $1.8M | -60.3% | 2.4 t | $738.96 | $10.0M | 12.8 t |
| October 2025 | $4.6M | +259.8% | 3.5 t | $1,333.50 | $9.0M | 11.8 t |
| September 2025 | $11.8M | +59.2% | 4.3 t | $2,721.54 | $9.3M | 15.2 t |
| August 2025 | $2.3M | -61.4% | 3.4 t | $662.85 | $8.3M | 13.6 t |
| July 2025 | $3.1M | +48.9% | 4.6 t | $679.94 | $9.7M | 14.1 t |
| June 2025 | $2.3M | -45.2% | 3.6 t | $634.24 | $12.1M | 15.6 t |
| May 2025 | $16.3M | +209.2% | 3.9 t | $4,235.07 | $9.1M | 13.8 t |
| April 2025 | $2.0M | -39.7% | 3.0 t | $681.13 | $10.1M | 14.5 t |
| March 2025 | $4.2M | +7.4% | 3.6 t | $1,169.83 | $8.2M | 11.7 t |
| February 2025 | $4.1M | -28.8% | 2.9 t | $1,435.35 | $10.4M | 13.0 t |
| January 2025 | $2.1M | -54.5% | 4.0 t | $517.60 | $8.4M | 10.3 t |
| December 2024 | $5.9M | +216.3% | 2.3 t | $2,582.58 | $11.0M | 12.7 t |
| November 2024 | $4.4M | +10.0% | 2.9 t | $1,503.26 | $8.4M | 12.5 t |
Exports FOB, imports CIF, US dollars. Weight is net weight. "vs year earlier" compares export value with the same month one year before and is left blank when that month was under $10,000. Source: Korea Customs Service, via data.go.kr.